Advertisement

ASCO CEO Dr. Clifford Hudis Commends President Obama, Vice President Biden, and Congress During 21st Century Cures Act Signing Ceremony

Advertisement

On Tuesday, December 13, President Obama signed into law the 21st Century Cures Act, landmark legislation designed to improve and accelerate the pace of biomedical research in the United States. ASCO Chief Executive Officer Clifford Hudis, MD, FACP, FASCO, attended the White House signing ceremony to witness the culmination of 3 years of intensive advocacy effort by ASCO and its members.

“This historic legislation brings new hope to millions of Americans facing life-threatening diseases and to their families,” said Dr. Hudis. “Not only does the 21st Century Cures Act reduce some of the major barriers to advancing cancer research, the measure also provides critical authority to federal research agencies to accomplish major priorities for the cancer community, including the Cancer Moonshot and Precision Medicine Initiatives.”

“Enacting 21st Century Cures is a momentous achievement and, potentially, an important pivot point for cancer research progress,” said Dr. Hudis. “ASCO commends President Obama, Vice President Biden, and Members of Congress for their leadership and commitment to bringing this legislation across the finish line.”

The content in this post has not been reviewed by the American Society of Clinical Oncology, Inc. (ASCO®) and does not necessarily reflect the ideas and opinions of ASCO®.


Advertisement

Advertisement




Advertisement